Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Working Capital to Net Assets Ratio
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Working Capital to Net Assets ratio of 53.7% as of September 2025. Working capital of CN¥2.00 Billion (current assets of CN¥3.08 Billion minus current liabilities of CN¥1.08 Billion) is measured against net assets of CN¥3.72 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 688553 equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sichuan Huiyu Pharmaceutical Co Ltd Working Capital to Net Assets (2017–2024)
This chart shows how Sichuan Huiyu Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 53.7%, reflecting working capital of CN¥2.00 Billion against net assets of CN¥3.72 Billion CNY. Check how tangible is Sichuan Huiyu Pharmaceutical Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Sichuan Huiyu Pharmaceutical Co Ltd (688553) total market value.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 55.6% | CN¥2.21 Billion | CN¥3.97 Billion | CN¥3.34 Billion | CN¥1.14 Billion | ▲ +2.8 pp |
| 2023 | 52.7% | CN¥1.99 Billion | CN¥3.77 Billion | CN¥2.87 Billion | CN¥879.32 Million | ▼ -10.4 pp |
| 2022 | 63.1% | CN¥2.35 Billion | CN¥3.72 Billion | CN¥2.87 Billion | CN¥526.39 Million | ▼ -13.9 pp |
| 2021 | 77.0% | CN¥2.74 Billion | CN¥3.56 Billion | CN¥3.23 Billion | CN¥492.91 Million | ▲ +28.6 pp |
| 2020 | 48.4% | CN¥363.64 Million | CN¥751.48 Million | CN¥760.77 Million | CN¥397.12 Million | ▲ +6.1 pp |
| 2019 | 42.3% | CN¥172.78 Million | CN¥408.65 Million | CN¥554.01 Million | CN¥381.24 Million | ▼ -92.0 pp |
| 2018 | 134.2% | CN¥-202.32 Million | CN¥-150.70 Million | CN¥100.24 Million | CN¥302.55 Million | ▼ -38.4 pp |
| 2017 | 172.6% | CN¥-319.89 Million | CN¥-185.32 Million | CN¥41.21 Million | CN¥361.11 Million | — |